Ads
related to: what is clinical hematology
Search results
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Cancer Clinical Trial Participation May Not Actually Improve Survival, Study Says
MedPage Today· 4 days agoCancer clinical trial participation was not associated with longer survival after accounting for...
Newswise Expert | Namrata Chandhok, University of Miami Health System, Miller School of Medicine
Newswise· 5 days agoNamrata Chandhok, M.D. is an Assistant Professor of Clinical Medicine (Hematology) at the University of Miami Miller School of Medicine/ Sylvester Comprehensive ...
Research shows new treatment may enable more patients with high-risk blood cancers to receive stem...
Medical Xpress· 2 days agoResults to be presented at the annual meetings of the American Society of Clinical Oncology (ASCO)...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 2 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
WPRI Providence· 6 days agoInternationally known clinical and translational researcher also co-leads the GI oncology team DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute ...
New thesis explores cancer treatment that can prevent relapse
Medical Xpress· 6 days agoMadeleine Lehander from the Hematology Unit/HERM, at the Department of Medicine, Huddinge (MedH), is...
ABVC CEO's Letter to Shareholders: The Future Looks Bright for ABVC; Anticipating Cash Incomes...
NewMediaWire via Yahoo Finance· 4 days agoFREMONT, CA - (NewMediaWire) - May 22, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 2 days ago(Nasdaq: RIGL) today announced upcoming presentations from their commercial and clinical-stage hematology and oncology portfolio at the 2024 American Society ...
...Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2...
WROC Rochester· 2 days agoBlueprint Medicines Corporation (Nasdaq: BPMC) today announced updated data from the ongoing Phase 1 dose escalation portion of the VELA clinical trial of BLU-222, an investigational ...